19 results
8-K
EX-99.1
BNTC
Benitec Biopharma Inc
13 Nov 23
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update
8:03am
of the comprehensive OPMD NH Study trial package to the Research Ethics Board (REB) for the lead clinical study site in Canada was completed, and Benitec awaits … the formal response from the REB.
Approval of the OPMD NH Study trial package by the REB is required for clinical study site activation and OPMD patient
8-K
EX-99.1
BNTC
Benitec Biopharma Inc
21 Sep 23
Financial Results and Provides Operational Update
8:05am
for enrollment into the Phase 1b/2a Clinical Treatment Study.
Formal submission of the comprehensive OPMD NH Study trial package to the Research Ethics Board … trial package by the REB is required for clinical study site activation and OPMD patient screening and enrollment to begin in Canada.
Financial
424B4
BNTC
Benitec Biopharma Inc
10 Aug 23
Prospectus supplement with pricing info
4:06pm
Study trial package to the Research Ethics Board (REB) for the lead clinical study site in Canada was completed, and Benitec awaits the formal response … from the REB.
Approval of the NH Study trial package by the REB is required for clinical study site activation and OPMD patient screening
8-K
EX-99.1
x5x66z ndfm5
15 May 23
Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update
8:05am
8-K
EX-99.1
g3wfxfy
10 Nov 22
Benitec Biopharma Releases First Quarter 2023 Financial
8:02am
8-K
EX-99.1
besznzwji
2 Sep 22
Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update
8:01am
8-K
EX-99.1
bm4b3owv
16 May 22
Benitec Biopharma Releases Q3 2022 Financial Results
8:00am
8-K
EX-1.1
1yhfq
29 Apr 21
Benitec Biopharma Announces $7.5 Million Bought Deal Offering of Common Stock
5:05pm
10-K
nv5 3vqrsb
23 Sep 20
Annual report
4:50pm
S-1
EX-10.3
wabxm
14 Aug 20
IPO registration
4:11pm
S-1
EX-10.4
tx0c8v tkv
14 Aug 20
IPO registration
4:11pm
S-1
r7z61tqf6kn5pfo
14 Aug 20
IPO registration
4:11pm
- Prev
- 1
- Next